Search

everythinglearnresearchcommunity

for

Search:↓

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride effectively treats hair loss in transgender men with few side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

AR gene not major factor in female hair loss; different from male hair loss.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Potassium levels affect blood sugar and insulin during dialysis, and malnutrition changes children's hair roots.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.